Templeton, A. J.
Rodríguez-Lescure, Á.
Ruíz, A.
Alba, E.
Calvo, L.
Ruíz-Borrego, M.
Santaballa, A.
Rodríguez, C. A.
Crespo, C.
Ramos, M.
Gracia-Marco, J. M.
Lluch, A.
Álvarez, I.
Casas, M. I.
Sánchez-Aragó, M.
Caballero, R.
Carrasco, E.
Amir, E.
Martin, M.
Ocaña, A. http://orcid.org/0000-0002-1067-9630
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy
https://doi.org/10.1007/s12094-018-1885-5
Article History
Received: 19 April 2018
Accepted: 26 April 2018
First Online: 15 May 2018
Compliance with ethical standards
:
: The GEICAM 9906 study was approved by the ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare that they have no conflict of interest.